Wuxi Advanced Therapies Inc.

UEI: DFL9LER9JCD9
CAGE: 8PGV3
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Expired Feb 18, 2026

Company facts

Self-certified in SAM.gov: For Profit Organization
Entity structure: Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov: 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary

621511 Medical Laboratories
SAM.gov registration date: Aug 7, 2020
Website: wuxiapptec.com
Founded: 2000
Employees: 10K-50K
Estimated annual revenue: $1B-$10B
Industry: Health Care

Pharmaceuticals, Biotechnology & Life Sciences

Pharmaceuticals
SIC code: 28 Chemical & Allied Products
Profiles: LinkedIn

X

Crunchbase

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Feb 18, 2026.

Wuxi Advanced Therapies Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award	Agency	Obligated	Awarded
Biologicals Contract · 75D30121P12794	CDC Pittsburgh	$103,000	Sep 21, 2021

Wuxi Advanced Therapies Inc.'s Unique Entity ID (UEI) in SAM.gov is DFL9LER9JCD9.

Wuxi Advanced Therapies Inc.'s CAGE code is 8PGV3.

Wuxi Advanced Therapies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Wuxi Advanced Therapies Inc.'s SAM.gov registration expired on February 18, 2026.

Wuxi Advanced Therapies Inc.'s most recent federal contract award is Biologicals (75D30121P12794), from CDC Pittsburgh, on September 21, 2021.

On GovTribe

Try for free Login